Literature DB >> 16322972

[Hip arthroscopy. Technique for positioning and distraction].

M Dienst1.   

Abstract

Arthroscopy of the hip joint can be performed in the supine or lateral position. The decision whether to use the supine or lateral position appears to be more a matter of individual training or habit. Both positions have specific pros and cons. The operative experience with arthroscopy of the central and peripheral compartment shows that a combined procedure with and without traction is beneficial. Whereas arthroscopy of the central compartment in normal joints of adults is feasible only with traction, the peripheral compartment can be better scoped without traction. The combination of both techniques however is technically demanding. Particularly for arthroscopy of the central compartment with traction, the success of the operative procedure is strongly correlated with a correct technique of positioning and distraction. Precise positioning and thick padding of the counterpost, secure fixation and thick padding of the foot, and the limitation of magnitude and duration of traction are important features in order to avoid soft tissue and nerve damage. Good relaxation, joint position, and distension of the joint to break the joint vacuum significantly improve distraction of the femoral head from the socket. In combination with fluoroscopy, scope trauma to the acetabular labrum and hyaline cartilage can be minimized. For arthroscopy of the peripheral compartment without traction, the counterpost is removed and the foot taken out of the traction module for free range of motion of the leg and hip joint. This allows dynamic testing of the hip and access to different parts of the peripheral labrum, proximal femur, and soft tissues.

Entities:  

Mesh:

Year:  2006        PMID: 16322972     DOI: 10.1007/s00132-005-0891-9

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  18 in total

Review 1.  [Arthroscopy for diagnosis and therapy of early osteoarthritis of the hip].

Authors:  M Dienst; R Seil; S Gödde; T Georg; D Kohn
Journal:  Orthopade       Date:  1999-09       Impact factor: 1.087

2.  Arthroscopy of the hip: 12 years of experience.

Authors:  H Dorfmann; T Boyer
Journal:  Arthroscopy       Date:  1999 Jan-Feb       Impact factor: 4.772

3.  Avoiding the labrum in hip arthroscopy.

Authors:  J W Byrd
Journal:  Arthroscopy       Date:  2000-10       Impact factor: 4.772

4.  Safe arthroscopic access to the central compartment of the hip.

Authors:  Michael Dienst; Romain Seil; Dieter M Kohn
Journal:  Arthroscopy       Date:  2005-12       Impact factor: 4.772

5.  Complications in hip arthroscopy.

Authors:  E L Funke; U Munzinger
Journal:  Arthroscopy       Date:  1996-04       Impact factor: 4.772

6.  Traction versus distension for distraction of the joint during hip arthroscopy.

Authors:  J W Byrd; K Y Chern
Journal:  Arthroscopy       Date:  1997-06       Impact factor: 4.772

7.  Hip arthroscopy utilizing the supine position.

Authors:  J W Byrd
Journal:  Arthroscopy       Date:  1994-06       Impact factor: 4.772

8.  [Indication and technique for hip arthroscopy: possibilities and limitations].

Authors:  E Funke; U Munzinger
Journal:  Schweiz Rundsch Med Prax       Date:  1994-02-08

9.  Pudendal nerve palsy complicating intramedullary nailing of the femur.

Authors:  R J Brumback; T S Ellison; H Molligan; D J Molligan; S Mahaffey; C Schmidhauser
Journal:  J Bone Joint Surg Am       Date:  1992-12       Impact factor: 5.284

Review 10.  Hip arthroscopy: current indications, treatment options, and management issues.

Authors:  Bryan T Kelly; Riley J Williams; Marc J Philippon
Journal:  Am J Sports Med       Date:  2003 Nov-Dec       Impact factor: 6.202

View more
  1 in total

1.  Good Outcome Scores and Low Conversion Rate to THA 10 Years After Hip Arthroscopy for the Treatment of Femoroacetabular Impingement.

Authors:  Lorenz Büchler; Valentin Grob; Helen Anwander; Till D Lerch; Pascal C Haefeli
Journal:  Clin Orthop Relat Res       Date:  2021-10-01       Impact factor: 4.755

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.